WO2014039767A1 - Electrochemical bioreactor module and methods of using the same - Google Patents
Electrochemical bioreactor module and methods of using the same Download PDFInfo
- Publication number
- WO2014039767A1 WO2014039767A1 PCT/US2013/058412 US2013058412W WO2014039767A1 WO 2014039767 A1 WO2014039767 A1 WO 2014039767A1 US 2013058412 W US2013058412 W US 2013058412W WO 2014039767 A1 WO2014039767 A1 WO 2014039767A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cathode
- anode
- mediator
- electron transport
- biological
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 57
- 238000000855 fermentation Methods 0.000 claims abstract description 59
- 230000004151 fermentation Effects 0.000 claims abstract description 59
- 238000006243 chemical reaction Methods 0.000 claims abstract description 50
- 238000004519 manufacturing process Methods 0.000 claims abstract description 34
- 230000008569 process Effects 0.000 claims abstract description 27
- 239000000126 substance Substances 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 47
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 40
- 230000002829 reductive effect Effects 0.000 claims description 38
- 239000012528 membrane Substances 0.000 claims description 32
- 102000004190 Enzymes Human genes 0.000 claims description 31
- 108090000790 Enzymes Proteins 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 238000006722 reduction reaction Methods 0.000 claims description 25
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 24
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 22
- 229910001868 water Inorganic materials 0.000 claims description 22
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 claims description 20
- 239000001384 succinic acid Substances 0.000 claims description 18
- 101150053185 P450 gene Proteins 0.000 claims description 16
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical group C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 14
- 102000004316 Oxidoreductases Human genes 0.000 claims description 10
- 108090000854 Oxidoreductases Proteins 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 9
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims description 8
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 239000012736 aqueous medium Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical group C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 claims description 6
- 230000031018 biological processes and functions Effects 0.000 claims description 6
- 239000004021 humic acid Substances 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 230000003134 recirculating effect Effects 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 3
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 claims 1
- 238000006479 redox reaction Methods 0.000 abstract description 14
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 238000010170 biological method Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 54
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 44
- 229910052799 carbon Inorganic materials 0.000 description 44
- 235000010633 broth Nutrition 0.000 description 32
- 244000005700 microbiome Species 0.000 description 26
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 25
- 239000008103 glucose Substances 0.000 description 25
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 21
- 238000013461 design Methods 0.000 description 21
- 238000007254 oxidation reaction Methods 0.000 description 21
- 241000894007 species Species 0.000 description 20
- 238000012546 transfer Methods 0.000 description 20
- 230000003647 oxidation Effects 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 230000009467 reduction Effects 0.000 description 18
- 235000011044 succinic acid Nutrition 0.000 description 17
- 229910002092 carbon dioxide Inorganic materials 0.000 description 16
- 230000036647 reaction Effects 0.000 description 16
- 230000027756 respiratory electron transport chain Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 230000004060 metabolic process Effects 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- -1 /'so-butanol Chemical compound 0.000 description 11
- 230000000813 microbial effect Effects 0.000 description 11
- 239000013626 chemical specie Substances 0.000 description 10
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 230000002503 metabolic effect Effects 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 8
- 235000011054 acetic acid Nutrition 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000004907 flux Effects 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 229950006238 nadide Drugs 0.000 description 7
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 6
- 230000005611 electricity Effects 0.000 description 6
- 239000000446 fuel Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 5
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000002551 biofuel Substances 0.000 description 5
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 5
- 239000003575 carbonaceous material Substances 0.000 description 5
- 230000037353 metabolic pathway Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 101150051438 CYP gene Proteins 0.000 description 4
- 239000000370 acceptor Substances 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000005518 electrochemistry Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 4
- 230000029553 photosynthesis Effects 0.000 description 4
- 238000010672 photosynthesis Methods 0.000 description 4
- 102100033149 Cytochrome b5 reductase 4 Human genes 0.000 description 3
- 108030005700 Cytochrome-b5 reductases Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102100023897 NADPH-cytochrome P450 reductase Human genes 0.000 description 3
- 230000002053 acidogenic effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229910001882 dioxygen Inorganic materials 0.000 description 3
- 239000010439 graphite Substances 0.000 description 3
- 229910002804 graphite Inorganic materials 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 102000007605 Cytochromes b5 Human genes 0.000 description 2
- 108010007167 Cytochromes b5 Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 102100036777 NADPH:adrenodoxin oxidoreductase, mitochondrial Human genes 0.000 description 2
- 102100033075 Prostacyclin synthase Human genes 0.000 description 2
- 150000001243 acetic acids Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000003889 chemical engineering Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000007831 electrophysiology Effects 0.000 description 2
- 238000002001 electrophysiology Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009285 membrane fouling Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- PVPBBTJXIKFICP-UHFFFAOYSA-N (7-aminophenothiazin-3-ylidene)azanium;chloride Chemical compound [Cl-].C1=CC(=[NH2+])C=C2SC3=CC(N)=CC=C3N=C21 PVPBBTJXIKFICP-UHFFFAOYSA-N 0.000 description 1
- JWQYZECMEPOAPF-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-2-ol Chemical compound C1=CC=C2CC(O)CCC2=C1 JWQYZECMEPOAPF-UHFFFAOYSA-N 0.000 description 1
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
- MNIQECRMTVGZBM-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;7h-purin-6-amine Chemical compound NC1=NC=NC2=C1NC=N2.CN1CCCC1C1=CC=CN=C1 MNIQECRMTVGZBM-UHFFFAOYSA-N 0.000 description 1
- 108090000187 Adrenodoxin Proteins 0.000 description 1
- 102000003804 Adrenodoxin Human genes 0.000 description 1
- 241000409326 Armiger Species 0.000 description 1
- 101150077024 CYP74A gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 241001508458 Clostridium saccharoperbutylacetonicum Species 0.000 description 1
- 108010046335 Ferredoxin-NADP Reductase Proteins 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 101001112118 Homo sapiens NADPH-cytochrome P450 reductase Proteins 0.000 description 1
- 101000653005 Homo sapiens Thromboxane-A synthase Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 108010045510 NADPH-Ferrihemoprotein Reductase Proteins 0.000 description 1
- 101710192343 NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical group NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 101710104207 Probable NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 101150016633 Ptgis gene Proteins 0.000 description 1
- 241000187562 Rhodococcus sp. Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 108010076830 Thionins Proteins 0.000 description 1
- 102100030973 Thromboxane-A synthase Human genes 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- WKHWEDWQNRRHQT-UHFFFAOYSA-J [C+4].C(=O)[O-].C(=O)[O-].C(=O)[O-].C(=O)[O-] Chemical group [C+4].C(=O)[O-].C(=O)[O-].C(=O)[O-].C(=O)[O-] WKHWEDWQNRRHQT-UHFFFAOYSA-J 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108060000307 allene oxide cyclase Proteins 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- MSSUFHMGCXOVBZ-UHFFFAOYSA-N anthraquinone-2,6-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 MSSUFHMGCXOVBZ-UHFFFAOYSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- BZHJMEDXRYGGRV-XPULMUKRSA-N chloro(1,2-14C2)ethene Chemical compound [14CH](=[14CH2])Cl BZHJMEDXRYGGRV-XPULMUKRSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 101150068868 cyp8 gene Proteins 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 150000002738 metalloids Chemical class 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000005817 monooxygenase reaction Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 108010064377 prostacyclin synthetase Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B15/00—Operating or servicing cells
- C25B15/02—Process control or regulation
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B15/00—Operating or servicing cells
- C25B15/08—Supplying or removing reactants or electrolytes; Regeneration of electrolytes
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B3/00—Electrolytic production of organic compounds
- C25B3/20—Processes
- C25B3/25—Reduction
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
- C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
- C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M8/00—Fuel cells; Manufacture thereof
- H01M8/16—Biochemical fuel cells, i.e. cells in which microorganisms function as catalysts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/50—Fuel cells
Definitions
- the invention relates generally to the use of biologically mediated reactions that alter the oxidation state of compounds, and specifically the oxidation state of carbon atoms in a given chemical compound.
- a reduction is the gaining of an electron by a particular chemical species and an oxidation is the loss of an electron from a particular chemical species.
- the general term redox reaction is short for oxidation-reduction reaction.
- a redox reaction is one which involves the transfer of electrons from one chemical species to another.
- Electrochemical cells are defined as systems that utilize a combination of redox reactions either to produce useful electrical energy, or use electrical energy to drive a combination of useful redox reactions (Silberberg, Martin (2009) Chemistry: The Molecular Nature of Matter and Change (5 th Ed.) New York, NY: McGraw-Hill).
- An electrochemical cell contains two electrodes known as the anode and the cathode.
- electrons In order to balance the depletion of electrons at the cathode, and the accumulation of electrons at the anode, electrons must flow from the anode to the cathode in some manner outside of the electrochemical cell, i.e. through a wire or some other material that allows the movement of electrons. This flow of electrons is an electrical current, and may be harnessed to perform work e.g. drive an electrical device.
- the flow of electrons from anode to cathode may be driven by an external power source, such as a battery, causing a useful chemical reaction to occur at either the anode or the cathode, or both.
- an external power source such as a battery
- An electrochemical cell can be constructed either to generate an electrical current, that is, a unidirectional flow of electrons through a conductive element such as a wire, from spontaneous redox reactions that occur at the anode and the cathode, or it can be constructed to consume electrical current provided by an external source, such as a battery, to drive non- spontaneous reactions at the anode and cathode. In the latter case, the electrically-driven, non- spontaneous reactions may be termed electrosynthesis.
- An electrochemical cell requires two reactions to occur, one at the anode and one at the cathode, the reactions occurring at each electrode are termed half-cell reactions, or half- reactions. Regardless of whether an electrochemical cell is consuming or generating an electrical current, half-cell reactions are necessarily occurring simultaneously at both the anode and the cathode.
- Half-cell reactions are considered to have a positive or negative
- redox potential reduction/oxidation potential
- the redox potential of the environment in the cathode chamber can be made more negative. This effect can be used to force half-cell reactions to the reduced species. To balance this, a half-cell reaction must necessarily be occurring in the anode chamber at the corresponding positive voltage, thus forcing the half-cell reaction at the anode to proceed to the oxidized species.
- any reaction which leads to a reduction or oxidation of a particular chemical species may provide a useful half-cell reaction.
- This includes living systems in which the desired half-reactions are present in metabolic pathways that perform the conversion of organic compounds and are catalyzed by enzymes.
- the half-cell reactions are generally termed redox reactions, hence the enzymes which catalyze such half-reactions are generally termed redox enzymes.
- redox enzymes require other biological components termed co-enzymes or co-factors, and it is these co-enzymes or co-factors which physically transport electrons between the various redox enzymes which catalyze the half- cell reactions (redox reactions) in a given biological system.
- micro-organisms In order for micro-organisms to generate organic molecules useful to the microorganism itself such as fatty acids for cellular membranes, or useful as a commercial product such as ethanol, it is necessary for a micro-organism to consume some form of carbon provided to the micro-organism. Typically this is a sugar or carbohydrate, but may be essentially any organic molecule that can be metabolized by the micro-organism. Further, the micro-organism must change the oxidation state of carbon atoms present in the carbon containing molecules provided to the microorganism, and this action is a major part of basic cellular metabolism. In order to oxidize a given carbon atom, the metabolic processes of the micro-organism must remove electrons from the carbon atom of interest, and in order to reduce a given carbon atom, the metabolic processes must provide electrons to the carbon atoms of interest.
- the metabolic processes in the micro-organism must oxidize some other chemical species to provide electrons for performing the desired reduction.
- reducing equivalents are generated by completely oxidizing a portion of the carbohydrate to C0 2 , that is, some of the carbohydrate provided to the micro-organism is sacrificially oxidized in order to provide electrons for the micro-organism to use in metabolic processes that produce organic molecules that are more reduced. While the resulting electrons are desirable and useful to the microorganism, the carbon atoms sacrificed by oxidation to C0 2 are lost.
- This loss of carbon atoms that were present in the original input sugar or carbohydrate reduces the amount of product that a micro-organism can make from a given mass of input carbonaceous material, e.g. sugar or carbohydrate.
- a microorganism in order for a microorganism to produce ethanol from the sugar glucose, it is necessary for the micro-organism to generate electrons for the metabolic steps which transform glucose to ethanol. This is accomplished by sacrificially oxidizing some of the glucose to C0 2 in order that the remaining glucose can be transformed to ethanol. In this process, for every 180 grs of glucose provided to a micro-organism for conversion to ethanol, 88 grs are lost as C0 2 and only 92 grs of ethanol are produced. Thus for every metric tonne of glucose provided to a commercial fermentation process, a maximum of only 511 kgs of ethanol can be produced, while 489 kgs of C0 2 are produced.
- Some biological systems can utilize hydrogen gas directly as a reducing agent, that is, as a source of electrons.
- hydrogen gas directly as a reducing agent
- the physical storage, transport and handling of hydrogen is unattractive.
- On-site generation of hydrogen gas may avoid some of those unattractive issues, but the necessary mixing of hydrogen gas in a fermentation system will be limited by the very low solubility of hydrogen in water, and the surface area of the gas/liquid interface between a bubble of hydrogen gas and the surrounding aqueous fluid.
- fermentor design and energy input for agitation must be considered and these are also unattractive. It is therefore desirable to introduce reducing equivalents as electrochemical species inherently compatible with heterogeneous aqueous biological systems.
- formate as both the carbon source as well as the reducing equivalents is the least effective method in terms of both carbon efficiency and energy utilization.
- isobutanol and 3-methyl-l-butanol (3MB) require two or three additional formate molecules (HCOO ) respectively, in addition to the four and five formate carbons respectively, forming the product backbone.
- additional formate carbon atoms are released by the cell as C0 2 from the engineered metabolic pathway.
- the organism will require a minimum of 6 or 7 formate carbons per isobutanol or 3MB molecule.
- a biological fuel cell is a device that directly converts microbial metabolic power into electricity using electrochemical technology.
- Allen “Cellular Electrophysiology", p. 247-283, In J. R. Norris and D. W. Ribbons (eds.). Methods in Microbiology. Academic Press, New York, 1992; Bennetto, et al., Biotechnol. Lett. 7:699-105, 1985; Roller et al., J. Chem. Tech. Biotechnol. 34B:3- 12, 1984; and Thurston, et al., J. Gen. Microbial. 131:1393-1401,1985.).
- Chemical energy may be converted to electric energy by coupling the
- the electrical enhancement of fermentations and biotransformations also involves the utilization of an electrode and electron mediator in a bioreactor system to enhance the production of reduced end products (see, Hongo ef al., Agri. Biolio. Chem., 43: 2075-20811 1979; Hongo et al., Agri. Biolio. Chem., 43: 2083-2086, 1979; Kim ef al., 1988; Park and Zeikus, J.
- Miyawaki ef al., supra is the lack of a facile system for regeneration or recycling of the electron transferring cofactors (e.g., nicotinamide adenine dinucleotide, quinones, flavin adenine dinucleotide, efc).
- the electron transferring cofactors e.g., nicotinamide adenine dinucleotide, quinones, flavin adenine dinucleotide, efc.
- neutral red would undergo reversible chemical oxidoreductions with nicotinamide adenine dinucleotide that is, neutral red in its reduced form (NR re d) has a sufficiently low redox value that it will transfer electrons to, and thus reduce, the redox cofactor NAD+ from its oxidized form to its reduced form NADH.
- neutral red becomes oxidized to the species N R 0X which is then available to accept an electron from the cathode and thus return to the reduced form N R re d, which is in turn available to reduce NAD+.
- microbes could grow on electricity alone; diverse microbes could over-produce a variety of reduced biochemicals during fermentations of
- U.S. Pat. No. 7,250,288 B2 to Zeikus ei al. discusses the need for improving electrode efficiencies in electrochemical bioreactor system and proposes improvements such as linking nicotinamide adenine dinucleotide (NAD + ), neutral red, and fumarate reductase to the electrode in order to improve electron transfer characteristics. While the above may improve electron transfer characteristics, it may also be advantageous to improve upon electrode design and electrochemical bioreactor system design in other ways.
- NAD + nicotinamide adenine dinucleotide
- Succinic Acid fermentation is a well-known process (see U.S. Patent Nos. 5,143,833;
- Providing reducing equivalents to a microorganism can be accomplished by regenerating NADH.
- the standard potential is often reported in the literature as -0.32V, however according to Karyakin ei al. a potential of -0.59V at pH 6 may be more accurate (see Karyakin et al., Electrochemistry Communications 5: 677-680, 2003).
- Various detectors for monitoring intracellular NADH have been described in U.S.
- Reduced electron shuttles can transfer electrons to several distinct electron- withdrawing compounds, such as azo dyes, polyhalogenated compounds, nitroaromatics and oxidized metalloids.
- Van der Zee and Cervantes review the results of reductive biotransformation process catalyzed by electron shuttles (see Frank P. Van der Zee and Francisco J. Cervantes.
- the methods revealed for accomplishing this in the examples provided therein require the anode to be contained in a manner that will prevent it from undergoing undesired reactions with the bulk biological system.
- some physical arrangement must be made to provide electron transfer to the anode, while keeping the anode physically separate from the fermentation broth (in the case of whole cells) or a buffer system (in the case of isolated enzymes in aqueous medium), and this is done with a variety of membranes, salt bridges or other physical means.
- FIG. 1 illustrates, in one embodiment, the overall electrochemistry and general arrangement of the electrochemical cell.
- FIG. 2 illustrates an exemplary device having two "sides" of the EBM System, the fermentor side, and the deionized water (Dl) side.
- FIG. 3 illustrates an exemplary EBM system design diagram.
- FIG. 4 illustrates an exemplary cathode chamber design.
- FIG. 5 illustrates an exemplary anode chamber design.
- FIG. 6 illustrates an exemplary electrolyzer portion of the EBM system.
- FIG. 7 shows graphically the difference in production of succinic acid by the control fermentor and the fermentor connected to the EBM unit.
- FIG. 8 shows graphically the dependence of current on flow rate of fermentation medium through the cathode chamber of the EBM unit.
- FIG. 9 shows the linear dependency of current on flow rate and the point at which this breaks down as the flow rate becomes too high.
- the present invention relates, in one aspect, to a device used to regulate carbon flux occurring in various metabolic processes of microorganisms with the aim to maximize carbon efficiency and product formation.
- embodiments of the present invention use biologically mediated reactions that alter the oxidation state of compounds, and specifically the oxidation state of carbon atoms in a given chemical compound. These reactions require the transfer of electrons either to or from the compound being acted upon by the biological mediator, such as an enzyme, group of enzymes, or whole microbial cell.
- the transfer of electrons can be performed using a physical device, e.g., an electrochemical cell, and more specifically, an electrochemical cell with integral instrumentation and various physical attributes which are advantageous to use for transferring electrons to or from biological systems which mediate reduction and oxidation reactions, and more specifically, the reduction and oxidation of carbon atoms to form useful compounds.
- a physical device e.g., an electrochemical cell, and more specifically, an electrochemical cell with integral instrumentation and various physical attributes which are advantageous to use for transferring electrons to or from biological systems which mediate reduction and oxidation reactions, and more specifically, the reduction and oxidation of carbon atoms to form useful compounds.
- the device of the present invention can be used as a means to transfer protons and electrons to a biological system, such as a whole cell, single enzyme, or group of enzymes with the reducing equivalents required to perform the desired redox reaction or reactions.
- cytochrome P450 and alcohol dehydrogenase of enzyme class EC 1.1. l.n or EC 1.1.1.-.
- a device comprising: an anode contained in an anode chamber and a cathode contained in a cathode chamber, the two chambers being separated by at least one membrane with allows water molecules, either neutral or positively charged, to pass through the membrane from one chamber to the other, wherein the anode chamber contains deionized water therein in contact with the anode; an aqueous medium containing a biological system in the cathode chamber in contact with the cathode, said biological system being capable of performing a reductive biological process; an external power source providing a voltage between the anode and the cathode; and a detection instrumentation having control means for controlling the reductive biological process.
- the aqueous medium further comprises an electron transport mediator.
- the device can further comprise a member for recirculating the aqueous medium from an external vessel through the cathode chamber and back in to the external container.
- the external vessel can be a fermentation tank.
- the device can have one or more separation membrane situated between the cathode and the biological system, such that the cathode is not in direct contact with the biological system.
- the separation membrane can create an additional compartment or compartments and can retain an electron transport mediator that is optionally in a fluid medium, such that the electron transport mediator can provide electron transport from the cathode through the intervening compartment to the biological system.
- the electron transport mediator can be humic acid and/or neutral red.
- a method of performing reductive processes in a biological system includes: providing the device described herein in which at least a portion of the biological system performing the reductive process is present in the cathode chamber; placing a suitable amount of an electron transport mediator in the cathode
- a method for the production of commodity chemicals includes using the device described herein for providing reducing equivalents to a fermentation process by: flowing a fermentation broth through the cathode chamber; applying voltage from the external power source between the anode and the cathode; and optionally utilizing an electron transport mediator by: (1) adding the mediator directly to the fermentation broth; or (2) providing the mediator on the separation membrane.
- the fermentation broth can include a fermentation product for the production of succinic acid, 1,4-butanediol, ethanol, /i-butanol, and/or iso- butanol.
- the fermentation broth can also comprise a micro-organism that has been altered to increase its ability to utilize electrons provided by the device described herein.
- the micro-organism has been genetically altered to express molecules in its cell membrane or surface which facilitate electron transport.
- a method of performing reductive processes in a biological system includes using the device described herein for providing reducing equivalents to a reaction catalyzed by a redox enzyme, wherein the reaction is in need of the reducing equivalents from a biological mediator, and wherein the redox enzyme receives the reducing equivalents from the cathode, optionally via an electron transport mediator.
- the biological mediator is NADH, NADPH and/or FMN H2.
- the enzyme can comprise a P450 enzyme and a P450 reductase.
- the enzyme can also comprise a modified P450 enzyme that has been engineered to include a P450 reductase activity.
- other commercial applications of the devices and/or methods of the present invention include the denitrification process in either drinking water or wastewater treatment in which a carbon source such as glycerol or methanol is added to the bioreactor to generate reducing equivalents for denitrifying bacteria.
- the present invention includes a system which can enable novel process technology that decouples hydrogen stoichiometry from carbon stoichiometry.
- Technology which decouples hydrogen stoichiometry from carbon stoichiometry is demonstrated by Flynn (see Flynn et al., mBio, 1 (5), pp. 1-8, 2010).
- the present invention involves a new process used to regulate carbon flux through metabolic pathways. Properly controlling the electrical current and voltage is essential to delivering reducing equivalents so that cellular metabolism, which is a series of tightly linked oxidation and reduction reactions, can be balanced to maximize product yield and process efficiency.
- the systems and devices described herein advantageously allow such control.
- Another advantage of the present invention is an on-line, continuous fluorometric detector for monitoring intracellular NADH or NADPH, ("NAD(P)H”) which will allow for a novel monitoring of cellular metabolism in real time.
- the present invention also advantageously simplifies the design of the
- the present invention additionally arranges the electrochemical cell in a manner that utilizes a simple half-reaction at the anode, and that operates in a manner to avoid the use of salt-bridges for connectivity of the anode and cathode chambers, and mitigates membrane fouling when a membrane is used to separate the anode and cathode chambers.
- the present invention is capable of direct physical incorporation into a continuously flowing loop running off of a fermentor or reactor, and can thus be used with existing
- the present invention in some embodiments, is termed an "Electrochemical
- the EBM comprises an electrochemical cell with an anode contained in an anode chamber, a cathode contained in a cathode chamber, and a membrane separating the two chambers.
- FIG. 1 which illustrates, in one embodiment, the overall
- the EBM System can have two “sides”, the fermentor side and the deionized water
- the fermentor side contains the fermentation broth, fermentor tank, fluorometric NADH sensors, optional ultrafiltration system for cell recycle and cell-free broth (which filters the fermentation broth to collect and recycle the cells and other solids back into the fermentor tank, while allowing the cell-free broth to continue to the cathode side, thereby avoiding blocking the fluid passage way in the cathode side with cells or other solids), fermentor pump, and cathode and cathode chamber of the electrolyzer, hydrogen gas collection and measurement system, pressure measurement system.
- the Dl side contains the Dl water reservoir, Dl water pump, water purification system (modules for duel resin deionization, filtration, ultraviolet sterilization and vacuum membrane degassing), oxygen collection and measurement systems, and anode and anode chamber of the electrolyzer.
- water purification system modules for duel resin deionization, filtration, ultraviolet sterilization and vacuum membrane degassing
- oxygen collection and measurement systems and anode and anode chamber of the electrolyzer.
- FIG. 3 illustrates an exemplary EBM system design diagram. It shows the main components of the EBM system, as well as the parameters that are measured and controlled throughout the system.
- the membrane used to separate the anode and cathode chamber is a modified Nafion ® (DuPont) membrane which allows only protons (as hydronium ions, H 3 0 + ) to travel across it.
- the membrane can contain an oxygen catalyst on the anode side, for the production of oxygen gas.
- the EBM can further include an electrochemical cell with an integrated instrumentation, that instrumentation comprising one or more of anode side oxygen collection system, cathode side gas collection system, flow rate control system, temperature measurement and control system, voltage and current measurement and regulation systems, pH measurement system, dissolved oxygen (DO) measurement system, conductivity measurement system, metabolic activity (fluorescence) measurement systems.
- instrumentation comprising one or more of anode side oxygen collection system, cathode side gas collection system, flow rate control system, temperature measurement and control system, voltage and current measurement and regulation systems, pH measurement system, dissolved oxygen (DO) measurement system, conductivity measurement system, metabolic activity (fluorescence) measurement systems.
- the anode can be any convenient design that allows useful current densities.
- the anode can be a titanium substrate coated with platinum.
- Such anode designs are now commercially available and used in electrolyzers.
- the anode chamber can be any convenient design that allows the input, recirculation, and temperature control of deionized water while simultaneously allowing the output, and optionally the collection, of gas generated at the anode surface, i.e. oxygen.
- FIG. 5 illustrates an exemplary anode chamber design.
- the anode chamber can be filled with deionized water, and a sufficient voltage is applied to cause the electrolytic cleavage of water. This results in the formation of oxygen gas in the anode chamber, which can be released to the atmosphere or captured for other use.
- the hydronium ions (H 3 0 + ) concomitantly produced migrate along the electric gradient and pass through the membrane separating the anode and cathode chamber. This causes a physical flux of water from the anode chamber into the cathode chamber.
- the cathode can be any convenient design that allows good current density and electron transfer to the electron transport mediator or directly to the biological system if no electron transport mediator is present.
- the cathode of the electrolyzer possesses parallel channels designed to increase surface area and to maximize fluid flow (with any suspended solid particles) while maximizing the overall electron transfer characteristics of the cathode.
- the cathode chamber of the EBM is designed for handling biological broths, e.g. fermentation broths, suspensions of whole cells and other heterogeneous biological mixtures.
- the cathode chamber can be any convenient design that allows fermentation broth or other heterogeneous mixtures to flow through the chamber.
- FIG. 4 illustrates an exemplary cathode chamber design.
- the cathode chamber consists of nine serpentine channels which are sized based on broth flow rate, viscosity and size of particulates in broth.
- the serpentine channels in the cathode chamber are also designed to enhance overall electron transfer from the cathode itself, without decreasing broth flow rate.
- the cathode chamber comprises a cathode primarily composed of carbon.
- This can be a solid piece of carbon that has been machined to have flow- channels or other physical shaping that increases surface area and contact time between the heterogeneous biological species and the cathode.
- the cathode chamber comprises a carbon electrode that is a thin sheet of carbon, carbon felt, or porous carbon.
- carbon paper This is commercially known as "carbon paper” and is available under the following brand names, Toray Carbon Paper TGP-H- 060, Carbon Paper AvCarb. Other similar products are also available and will be known to those skilled in the art.
- FIG. 6 illustrates an exemplary electrolyzer portion of the EBM system. Flow of the fermentation broth through the cathode chamber (B) and water through the anode chamber (H) is shown.
- the electrolyzer can have an endplate (A, I) at either end.
- a modified PEM protein exchange membrane, F
- Silicon gaskets (E, G) can be used to flank the PEM.
- One or more optional membranes (D) can be placed in the electrolyzer.
- an optional electron transport mediator can be added to the EBM system.
- the electron transport mediator can be mixed with the fermentation broth (which can contain a biological system such as cells and/or enzyme(s)) and fed into the cathode chamber.
- the electron transport mediator can also be retained in or by a membrane (e.g., beneath the membrane or within an external compartment attached to the membrane) positioned within the cathode chamber that separates the cathode from the biological system.
- the proposed system can use humic substances as an electron transport mediator.
- Humic substances have been shown to shuttle electrons between humic- reducing microorganism and Fe(lll) oxide, as well as from microorganisms to the humic acid (see Lovley ef al. "Humic substances as electron acceptors for microbial respiration” Nature 382, August 1996).
- neutral red can also be used as an electron-transport mediator.
- Neutral Red works principally via the direct chemical reduction of the redox cofactors such as nicotine adenine dinucleotide, NAD+ (Park and Zeikus, J. Bacteriol. 181: 403-2410, 1999).
- the EBM provides a method to reduce or eliminate the sacrificial loss of carbon used to generate reducing equivalents that occurs during metabolism by whole cells, either as an active fermentation or as resting cells held in a physiologically acceptable medium that allows the cells to continue metabolism but restricts or prevents cell growth.
- the reduction or elimination of the unwanted metabolic pathways will increase desired carbon flux, and reduce unwanted C0 2 production.
- using the EBM system for production of exemplary compounds such as ethanol, n-butanol, isobutanol, 3MB or succinic acid will significantly increase carbon efficiency.
- the independent control of the carbon stoichiometry and the hydrogen stoichiometry should permit regulation of the isobutanol to 3MB ratio.
- the EBM system can be used to provide reducing equivalents to an isolated redox enzyme in the absence of whole cells.
- the enzyme can comprise a P450 enzyme and a P450 reductase.
- the enzyme can also comprise a modified P450 enzyme that has been engineered to include a P450 reductase activity.
- the EBM system can be easily interfaced with existing capital equipment such as a large fermentor. Therefore, the EBM system can be readily utilized in advancing process engineering technology leading to increased efficiency of bio-based chemicals and biofuel production.
- the biological process stream is simply circulated through the cathode chamber and allowed to contact the cathode directly.
- electron transfer occurs directly from the cathode to the biological species, but rates of electron transfer may be slow.
- an electron transport mediator can be added to the recirculating biological system in order to increase proton and electron transfer to the desired biological species.
- the mediator can be circulated through the device on the cathode side where it comes in contact with the cathode. Protons and electrons are transferred to the mediator, which then transfers these protons and electrons to the biological species. The mediator is recycled in this process and comes in contact with the cathode again to repeat the process.
- concentration of electron mediator will be adjusted according to desired electron and proton transport characteristics.
- the electron transport mediator is contained behind or beneath an additional membrane, or is tethered or bound to the cathode to give a very high local concentration without having to be present in large volumes of the biological process stream(s).
- a membrane can be interposed between the cathode and the biological system such that the optional membrane allows the passage of the electron transport mediator from the biological system to the cathode and back again, while preventing the physically larger components of the biological system, e.g. cells, cell debris, entrained solid particles, or even enzymes from contacting the cathode or entering the cathode chamber.
- the optional membrane allows the passage of the electron transport mediator from the biological system to the cathode and back again, while preventing the physically larger components of the biological system, e.g. cells, cell debris, entrained solid particles, or even enzymes from contacting the cathode or entering the cathode chamber.
- EBM Use of the EBM is not restricted to whole cells.
- Other physical and operational embodiments include the use of isolated enzymes and P450.
- cytochrome P450 superfamily (abbreviated as cytochrome P450 superfamily
- CYP is a group of enzymes that catalyze the oxidation of organic substances.
- the most common reaction catalyzed by cytochromes P450 is a monooxygenase reaction, e.g., insertion of one atom of oxygen into an organic substrate (RH) while the other oxygen atom is reduced to water: RH + 0 2 + NADPH + H + -> ROH + H 2 0 + NADP +
- CYPs Based on the nature of the electron transfer proteins CYPs can be classified into several groups:
- Cytochrome b5 (cyb5) can also contribute reducing power to this system after being reduced by cytochrome b5 reductase (CYB5R).
- FMN/Fd/P450 systems originally found in Rhodococcus sp. in which a FMN-domain-containing reductase is fused to the CYP.
- P450 only systems which do not require external reducing power. Notable ones include CYP5 (thromboxane synthase), CYP8 (prostacyclin synthase), and CYP74A (allene oxide synthase).
- two or multiple electrolyzer assemblies within the EBM can be used in series or in a stacked pattern alternating anode and cathode plates with flow chambers on each side. This can provide decreased hardware costs and well as more efficient electrical conditions.
- the anode chamber is filled with deionized water
- the cathode chamber is filled with the bulk biological system to which electrons are to be transferred
- an external electric current of sufficient voltage is applied between the anode and the cathode such that water is electrolytically cleaved at the anode causing the flow of electrons into the anode and the formation of neutral oxygen (0 2 ) and positively charged hydronium ions (H 3 0 + ) in the anode chamber
- the cathode provided from the cathode, either by direct transfer of electrons from the cathode, or via the transfer of electrons from the cathode to an electron transport mediator and then to the biological system, and/or
- protons from the hydronium ions migrating from the anode chamber are disposed into the bulk biological system to balance the electrons that have been transferred to the biological system from the cathode.
- Each flask of inoculum medium is itself inoculated with 0.2 ml of thawed stock culture and allowed to grow on a shaker at 250 rpm and 37°C for 16 hours at which time it is used to inoculate the 5 liters of growth broth in the two 7-liter fermentors.
- Each fermentor is allowed to grow aerobically (1 vvm) for 9 hours with active pH control at pH 6.5.
- the second fermentor is connected to the highly-instrumented EBM via an external recirculation loop in order to demonstrate the impact of providing exogenous reducing equivalents to the biological system, i.e. the fermentation broth.
- the entire contents of the second fermentor are continuously recycled between the 7-liter fermentation vessel and the Electrochemical Bioreactor Module (EBM).
- EBM Electrochemical Bioreactor Module
- a computer-controlled peristaltic pump is used to adjust the flow rate from the fermentor through the EBM unit at the desired flow rate.
- a voltage of -2.5 V is applied to the EBM and the current is measured at 1 second intervals.
- the current provided to the EBM over 24 hours ranges from 1.5 amps to 3.1 amps with an average value of approximately 1.9 to 2.0 amps. At these conditions, the EBM unit has a Faradaic Efficiency of 78%.
- Broth samples are taken from the control fermentor and from the fermentor connected to the EBM unit to determine the levels of glucose and succinic acid, as well as levels of anticipated by-products lactic and acetic acids by high-performance liquid chromatography. The results are shown in Figure 7 and in Table 1 below.
- the fermentor connected to the EBM consumed 0.60 moles of glucose while producing 0.77 moles of succinic acid, plus 0.05 moles of lactic acid, but only produced 0.04 moles of acetic acid over the same time period (6.5 hours to 24 hours).
- the current measured in the electrolyzer which runs at a Faradaic Efficiency of 78% for operating conditions described above, results in delivering 0.260 moles of electrons (plus the corresponding number of hydronium ions, i.e. reducing equivalents) to the connected fermentation vessel, i.e. 0.260 moles of reducing equivalents.
- control fermentor produced succinic acid according to the following stoichiometry:
- Example B Effect of Flow Rate on Electrolvzer Current
- the ability of a given unit volume of fermentation broth to accept reducing equivalents from the cathode chamber of the EBM unit is limited by unit volume's ability to transfer those reducing equivalents to a metabolic process in the fermentation vessel.
- no more exogenously provided reducing equivalents i.e. electrons and hydronium ions
- the current in the cathode chamber will increase as the EBM delivers reducing equivalents to the metabolic processes demanding more reducing equivalents.
- Example A In order to demonstrate the dependency of current on flow rate of fermentation broth through the EBM unit, a mixed-culture fermentation is prepared in the same manner as Example A.
- the mixed culture can contain E.coli, Lactobacillus sp. or other convenient microorganisms that are good producers of metabolic products requiring the consumption of reducing equivalents, such as lactic acid or succinic acid.
- reducing equivalents such as lactic acid or succinic acid.
- Various flow rates through the EBM unit from 0 to 3 LPM are run to determine the impact of flow rate on current. The current values measured at various pump speeds are shown graphically in Figure 8.
- FIG. 9 shows that current passing through the EBM unit becomes non-linearly dependent on the flow rate of the fermentation medium through the cathode chamber after the flow rate reaches a critical value. This is the flow rate at which the fermentation broth relatively depleted in reducing equivalents has such a short residence time in the cathode chamber that the EBM unit cannot fully regenerate the entire redox pool before the broth exits the cathode chamber. At flow rates above this critical value, the current will asymptotically approach a constant value and effectively will no longer be dependent on flow rate.
- Example A In order to further test the control and regulation aspects of the EBM system a series of samples are generated in the same manner as Example A with the exception of applied voltage across the anode and cathode of the EBM. Various voltages between 0.0 V and -4.0 V are used. The voltages are varied to determine the optimum potential for succinic acid production, up to the maximum possible voltage before the Faradaic Efficiency reaches 100% as measured by hydrogen gas production. The succinic acid production is measured along with all other parameters in Example A.
- Example A In order to test the performance of electron transport mediators in the EBM system a series of samples are generated in the same manner as Example A with the following exceptions; the mediator type and concentration are varied in the fermentation broth. Mediators of humic acid, Neutral Red, methyl viologen, and anthraquinone-2,6-disulfonate, are used in various concentrations ranging from 0 M to the given mediator's limit of solubility in the fermentation broth. The succinic acid production is measured along with all other parameters in Example A.
- a culture of Clostridium saccharoperbutylacetonicum N l-4 (ATCC13564) is grown and is allowed to proceed through the acidogenic phase. Upon depletion of glucose, methyl viologen is added to the fermentation broth and the fermentation broth is recirculated through the EBM. The production of /i-butanol and decrease of butyrate is monitored to show the production of /i-butanol in the absence of glucose.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Automation & Control Theory (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Manufacturing & Machinery (AREA)
- Sustainable Development (AREA)
- Sustainable Energy (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13835540.9A EP2893587B1 (en) | 2012-09-09 | 2013-09-06 | Electrochemical bioreactor module and methods of using the same |
CA2923794A CA2923794C (en) | 2012-09-09 | 2013-09-06 | Electrochemical bioreactor module and methods of using the same |
US14/426,828 US11929532B2 (en) | 2012-09-09 | 2013-09-06 | Electrochemical bioreactor module and methods of using the same |
BR112015005172-3A BR112015005172B1 (en) | 2012-09-09 | 2013-09-06 | ELECTROCHEMICAL BIOREACTOR MODULE AND METHODS TO USE THE SAME |
CN201380050739.7A CN104871357B (en) | 2012-09-09 | 2013-09-06 | Electrochemica biological reactor module and the method for using the module |
HK16102184.4A HK1214412A1 (en) | 2012-09-09 | 2016-02-25 | Electrochemical bioreactor module and methods of using the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261698702P | 2012-09-09 | 2012-09-09 | |
US61/698,702 | 2012-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014039767A1 true WO2014039767A1 (en) | 2014-03-13 |
Family
ID=50237622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/058412 WO2014039767A1 (en) | 2012-09-09 | 2013-09-06 | Electrochemical bioreactor module and methods of using the same |
Country Status (7)
Country | Link |
---|---|
US (1) | US11929532B2 (en) |
EP (1) | EP2893587B1 (en) |
CN (1) | CN104871357B (en) |
BR (1) | BR112015005172B1 (en) |
CA (1) | CA2923794C (en) |
HK (1) | HK1214412A1 (en) |
WO (1) | WO2014039767A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016070168A1 (en) | 2014-11-02 | 2016-05-06 | Biocheminsights, Inc. | Improved electrochemical bioreactor module and use thereof |
JP2016140322A (en) * | 2015-02-03 | 2016-08-08 | 一般財団法人電力中央研究所 | Electron mediator for electrical cultivation |
WO2016137976A1 (en) * | 2015-02-23 | 2016-09-01 | Biocheminsights, Inc. | Electrochemical bioreactor module and engineered metabolic pathways for 1- butanol production with high carbon efficiency |
WO2017160793A1 (en) | 2016-03-14 | 2017-09-21 | Biocheminsights, Inc. | Improved method for using electrochemical bioreactor module with recovery of cofactor |
EP3316375B1 (en) | 2015-06-23 | 2020-03-18 | Panasonic Intellectual Property Management Co., Ltd. | Redox flow cell |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016049061A1 (en) * | 2014-09-22 | 2016-03-31 | Lawrence Livermore National Security, Llc | Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems |
CN105647981B (en) * | 2016-03-29 | 2019-06-04 | 南京工业大学 | Method for enhancing glycerol utilization of microbial cells through electrochemical system and application of method |
CN108728860B (en) * | 2018-03-30 | 2019-04-09 | 四川大学 | A kind of riboflavin promotion low concentration CO2The method of electrochemistry trapping |
CN109830698B (en) * | 2019-02-18 | 2022-02-08 | 湖南农业大学 | Preparation method of electrode with hollow fold structure |
CN110320262A (en) * | 2019-07-04 | 2019-10-11 | 福建省医学科学研究院 | A method of characterization bioenergetic metabolism |
CN110284150A (en) * | 2019-07-26 | 2019-09-27 | 华东理工大学 | A method of promoting microorganism electrochemical chemical recycling of carbon dioxide methane phase |
CN112501213B (en) * | 2020-06-23 | 2023-06-06 | 哈尔滨工业大学 | Cathode electrofermentation method for preparing hydrogen and butanol by enhancing clostridium beijerinckii fermentation by using electron transfer mediator |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4577110A (en) | 1983-04-11 | 1986-03-18 | Biochem Sensors, Inc. | Optical apparatus and method for measuring the characteristics of materials by their fluorescence |
US5143833A (en) | 1986-06-11 | 1992-09-01 | Rathin Datta | Process for the production of succinic acid by anaerobic fermentation |
US5401412A (en) | 1993-07-20 | 1995-03-28 | Biochem Technology, Inc. | Method and apparatus for monitoring biological activity in wastewater and controlling the treatment thereof |
US5466604A (en) | 1994-03-08 | 1995-11-14 | Biochem Technology, Inc. | Apparatus for monitoring biological activity in wastewater and controlling the treatment thereof |
US5504004A (en) | 1994-12-20 | 1996-04-02 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
US5573931A (en) | 1995-08-28 | 1996-11-12 | Michigan Biotechnology Institute | Method for making succinic acid, bacterial variants for use in the process, and methods for obtaining variants |
US6270649B1 (en) | 1998-07-09 | 2001-08-07 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
US6495023B1 (en) * | 1998-07-09 | 2002-12-17 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
US20040101741A1 (en) | 2002-11-27 | 2004-05-27 | St. Louis University | Enzyme immobilization for use in biofuel cells and sensors |
US6743610B2 (en) | 2001-03-30 | 2004-06-01 | The University Of Chicago | Method to produce succinic acid from raw hydrolysates |
US20050032195A1 (en) | 2003-08-06 | 2005-02-10 | Board Of Trustees Of Michigan State University | Actinobacillus succinogenes shuttle vector and methods of use |
US20050158618A1 (en) * | 1998-08-19 | 2005-07-21 | Powerzyme, Inc. | Enzymatic fuel cell |
US20050287399A1 (en) * | 2004-06-24 | 2005-12-29 | Ladisch Michael R | Bio-battery |
US20060251959A1 (en) | 2003-06-27 | 2006-11-09 | Dimitre Karamanev | Biofuel cell |
US7250288B2 (en) | 2001-05-31 | 2007-07-31 | Board Of Trustees Of Michigan State University | Electrode compositions and configurations for electrochemical bioreactor systems |
US20070259216A1 (en) * | 2006-05-02 | 2007-11-08 | The Penn State Research Foundation | Substrate-enhanced microbial fuel cells |
US20080305533A1 (en) | 2004-12-22 | 2008-12-11 | Oracle International Corporation | Recombinant Microorganisms For Increased Production of Organic Acids |
US20100040909A1 (en) | 2003-06-27 | 2010-02-18 | The University Of Western Ontario | Bio-fuel cell system |
US7767323B1 (en) * | 2006-12-19 | 2010-08-03 | University Of South Florida | Microbial fuel cell |
WO2011087821A2 (en) | 2009-12-22 | 2011-07-21 | University Of Massachusetts | Microbial production of multi-carbon chemicals and fuels from water and carbon dioxide using electric current |
US20120052542A1 (en) | 2009-03-10 | 2012-03-01 | Athena Biotechnologies, Inc. | Reducing Carbon Dioxide Production and Increasing Ethanol Yield During Microbial Ethanol Fermentation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20061799A1 (en) * | 2006-09-21 | 2008-03-22 | Industrie De Nora Spa | ELECTROLYSIS CELL FOR THE PRODUCTION OF OXYGENATED WATER AND METHOD OF USE |
EP2697730A4 (en) * | 2011-04-15 | 2015-04-15 | Advanced Diamond Technologies Inc | Electrochemical system and method for on-site generation of oxidants at high current density |
KR101276660B1 (en) * | 2011-05-04 | 2013-06-19 | 알엠텍 주식회사 | Method for removal of heavy metals or recovery of precious metals using a microbial fuel cell |
WO2013123425A1 (en) * | 2012-02-15 | 2013-08-22 | Bio-Rad Laboratories, Inc. | Electronic control of ph and ionic strength |
SG10201609434XA (en) * | 2012-05-10 | 2017-01-27 | Synthetic Genomics Inc | Microbial fuel cell |
-
2013
- 2013-09-06 US US14/426,828 patent/US11929532B2/en active Active
- 2013-09-06 BR BR112015005172-3A patent/BR112015005172B1/en active IP Right Grant
- 2013-09-06 WO PCT/US2013/058412 patent/WO2014039767A1/en active Application Filing
- 2013-09-06 CN CN201380050739.7A patent/CN104871357B/en active Active
- 2013-09-06 CA CA2923794A patent/CA2923794C/en active Active
- 2013-09-06 EP EP13835540.9A patent/EP2893587B1/en active Active
-
2016
- 2016-02-25 HK HK16102184.4A patent/HK1214412A1/en unknown
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4577110A (en) | 1983-04-11 | 1986-03-18 | Biochem Sensors, Inc. | Optical apparatus and method for measuring the characteristics of materials by their fluorescence |
US5143833A (en) | 1986-06-11 | 1992-09-01 | Rathin Datta | Process for the production of succinic acid by anaerobic fermentation |
US5401412A (en) | 1993-07-20 | 1995-03-28 | Biochem Technology, Inc. | Method and apparatus for monitoring biological activity in wastewater and controlling the treatment thereof |
US5466604A (en) | 1994-03-08 | 1995-11-14 | Biochem Technology, Inc. | Apparatus for monitoring biological activity in wastewater and controlling the treatment thereof |
US5504004A (en) | 1994-12-20 | 1996-04-02 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
US5723322A (en) | 1994-12-20 | 1998-03-03 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
US5573931A (en) | 1995-08-28 | 1996-11-12 | Michigan Biotechnology Institute | Method for making succinic acid, bacterial variants for use in the process, and methods for obtaining variants |
US6270649B1 (en) | 1998-07-09 | 2001-08-07 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
US6495023B1 (en) * | 1998-07-09 | 2002-12-17 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
US20050158618A1 (en) * | 1998-08-19 | 2005-07-21 | Powerzyme, Inc. | Enzymatic fuel cell |
US6743610B2 (en) | 2001-03-30 | 2004-06-01 | The University Of Chicago | Method to produce succinic acid from raw hydrolysates |
US7250288B2 (en) | 2001-05-31 | 2007-07-31 | Board Of Trustees Of Michigan State University | Electrode compositions and configurations for electrochemical bioreactor systems |
US20040101741A1 (en) | 2002-11-27 | 2004-05-27 | St. Louis University | Enzyme immobilization for use in biofuel cells and sensors |
US20060251959A1 (en) | 2003-06-27 | 2006-11-09 | Dimitre Karamanev | Biofuel cell |
US20100040909A1 (en) | 2003-06-27 | 2010-02-18 | The University Of Western Ontario | Bio-fuel cell system |
US20050032195A1 (en) | 2003-08-06 | 2005-02-10 | Board Of Trustees Of Michigan State University | Actinobacillus succinogenes shuttle vector and methods of use |
US20050287399A1 (en) * | 2004-06-24 | 2005-12-29 | Ladisch Michael R | Bio-battery |
US20080305533A1 (en) | 2004-12-22 | 2008-12-11 | Oracle International Corporation | Recombinant Microorganisms For Increased Production of Organic Acids |
US20070259216A1 (en) * | 2006-05-02 | 2007-11-08 | The Penn State Research Foundation | Substrate-enhanced microbial fuel cells |
US7767323B1 (en) * | 2006-12-19 | 2010-08-03 | University Of South Florida | Microbial fuel cell |
US20120052542A1 (en) | 2009-03-10 | 2012-03-01 | Athena Biotechnologies, Inc. | Reducing Carbon Dioxide Production and Increasing Ethanol Yield During Microbial Ethanol Fermentation |
WO2011087821A2 (en) | 2009-12-22 | 2011-07-21 | University Of Massachusetts | Microbial production of multi-carbon chemicals and fuels from water and carbon dioxide using electric current |
Non-Patent Citations (47)
Title |
---|
AICHE: "Update: Plug-In Bacteria Produce Fuel from CO", CHEMICAL ENGINEERING PROGRESS, May 2012 (2012-05-01), pages 12 - 13 |
ALLEN: "Methods in Microbiology", 1992, ACADEMIC PRESS, article "Cellular Electrophysiology", pages: 247 - 283 |
ARDELEANU ET AL., BIOELECTROCHEM. BIOENERG, vol. 11, 1983, pages 273 - 277 |
ARMIGER ET AL., CHEMICAL ENGINEERING COMMUNICATIONS, vol. 45, no. 1, 1986, pages 197 - 206 |
BENNETTO ET AL., BIOTECHNOL. LETT., vol. 7, 1985, pages 699 - 105 |
BRADLEY ET AL., APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 64, no. 8, 1998, pages 3102 - 3105 |
D. MIYAWAKI ET AL., ENZG. MICROBIOL. TECHNOL., vol. 15, 1993, pages 525 - 29 |
DELANEY ET AL., CHEM. TECH. BIOTECHNOL., vol. 34b, 1985, pages 13 - 27 |
FLYNN ET AL., MBIO, vol. 1, no. 5, 2010, pages 1 - 8 |
FRANK P. VAN DER ZEE; FRANCISCO J. CERVANTES, BIOTECHNOLOGY ADVANCES, vol. 27, 2009, pages 265 - 277 |
FULTZ, ANAL. CHIM. ACTA., vol. 140, 1982, pages 1 - 18 |
HONGO ET AL., AGRI. BIOLIO. CHEM., vol. 43, 1979, pages 2075 - 20811 |
HONGO ET AL., AGRI. BIOLIO. CHEM., vol. 43, 1979, pages 2083 - 2086 |
HUMPHREY ET AL.: "Squires", vol. 124, 1980, AMERICAN CHEMICAL SOCIETY, pages: 355 - 366 |
KARYAKIN ET AL., ELECTROCHEMISTRY COMMUNICATIONS, vol. 5, 2003, pages 677 - 680 |
KIM ET AL., BIOCHEM. BIOPHYS. RES. COM., vol. 180, 1982, pages 11276 - 1130 |
KIM ET AL., J. MICROBIAL. BIOTECHNOL., vol. 9, 1999, pages 127 - 13 |
LOVLEY ET AL.: "Humic substances as electron acceptors for microbial respiration", NATURE, vol. 382, August 1996 (1996-08-01) |
MACHADO, C: "Technical Characteristics and Current Status of Butanol Production and Use as Biofuel", BIO V SEMINARIO LATINOAMERICANO Y DEL CARIBE DE BIOCOMBUSTIBLES 2010, 17 August 2010 (2010-08-17) |
MORIMYO, J. BACTERIOL., vol. 170, 1988, pages 2136 - 2142 |
NGHIEM, APPL BIOCHEM BIOTECHNOL, vol. 162, 2010, pages 1915 - 1928 |
P. N. BARTLETT, MED. AND BIOL. ENG. AND COMPUT., vol. 28, 1990 |
PARK ET AL., APPL. ENVIRON. MICROBIOI., 1990, pages 2912 - 2917 |
PARK ET AL., APPL. ENVIRON. MICROBIOI., vol. 65, 1999, pages 2912 - 2917 |
PARK ET AL., BIOTECH. LETT., vol. 22, 2000, pages 1301 - 1304 |
PARK ET AL., BIOTECH. TECHNIQ., vol. 11, 1997, pages 145 - 148 |
PARK ET AL., J. BACTERIOL., vol. 1812, 1999, pages 2403 - 2410 |
PARK; ZEIKUS, APPL. ENVIRON. MICROBIOL., vol. 66, 2000, pages 1292 - 1297 |
PARK; ZEIKUS, J. BACTERIOL., vol. 181, 1999, pages 2403 - 2410 |
PARK; ZEIKUS, J. BACTERIOL., vol. 181, 1999, pages 403 - 2410 |
RISTROPH ET AL., JOURNAL OF FERMENTATION TECHNOLOGY, vol. 55, no. 6, 1977, pages 599 |
ROLLER ET AL., J. CHEM. TECH. BIOTECHNOL., vol. 34B, 1984, pages 3 - 12 |
S. M. ROBERTS ET AL., CHIMICAOGGI, July 1993 (1993-07-01), pages 93 - 104 |
See also references of EP2893587A4 |
SHIN ET AL., APPL MICROBIOL BIOTECHNOL., 22 September 2001 (2001-09-22) |
SILBERBERG, MARTIN: "Chemistry: The Molecular Nature of Matter and Change", 2009, MCGRAW-HILL |
SONG, H.; S.Y. LEE, ENZYME AND MICROBIAL TECHNOLOGY, vol. 39, no. 1, 2006, pages 352 - 361 |
SONOMOTO ET AL., JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 104, no. 3, 2007, pages 238 - 240 |
SONOMOTO, JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 104, no. 3, 2007, pages 238 - 240 |
TANAKA ET AL., CHEM. TECH. BIOTECHNOL., vol. 35B, 1985, pages 191 - 197 |
TANAKA ET AL., CHEM. TECH. BIOTECHNOL., vol. 42, 1988, pages 235 - 240 |
THURSTON ET AL., J. GEN. MICROBIAL., vol. 131, 1985, pages 1393 - 1401 |
WALSH, F.; G. READE, ANALYST, vol. 119, no. 1, May 1994 (1994-05-01), pages 797 - 803 |
WILLNER ET AL., BIOELECTROCHEM. BIOENERG, vol. 44, 1998, pages 209 - 214 |
Z. STRUYK; GARRISON SPOSITO, GEODERMA, vol. 102, 2001, pages 329 - 246 |
ZEIKUS ET AL., JOURNAL OF BACTERIOLOGY, vol. 181, no. 8, April 1999 (1999-04-01), pages 2403 - 2410 |
ZHU ET AL., ANNU. REV. PLANT BIOL., vol. 61, 2010, pages 235 - 61 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016070168A1 (en) | 2014-11-02 | 2016-05-06 | Biocheminsights, Inc. | Improved electrochemical bioreactor module and use thereof |
CN107250436A (en) * | 2014-11-02 | 2017-10-13 | 百奥堪引赛股份有限公司 | Improved electrochemica biological reactor module and application thereof |
US11459663B2 (en) | 2014-11-02 | 2022-10-04 | Biocheminsights, Inc. | Electrochemical bioreactor module and use thereof |
JP2016140322A (en) * | 2015-02-03 | 2016-08-08 | 一般財団法人電力中央研究所 | Electron mediator for electrical cultivation |
WO2016137976A1 (en) * | 2015-02-23 | 2016-09-01 | Biocheminsights, Inc. | Electrochemical bioreactor module and engineered metabolic pathways for 1- butanol production with high carbon efficiency |
CN107849584A (en) * | 2015-02-23 | 2018-03-27 | 百奥堪引赛股份有限公司 | The electrochemica biological reactor module and engineering metabolic pathway of 1 butanol are produced with high carbon efficiencies |
EP3262179A4 (en) * | 2015-02-23 | 2018-07-11 | Biocheminsights Inc. | Electrochemical bioreactor module and engineered metabolic pathways for 1- butanol production with high carbon efficiency |
US10696988B2 (en) | 2015-02-23 | 2020-06-30 | Biocheminsights, Inc. | Methods and systems for 1-butanol production |
US11512328B2 (en) | 2015-02-23 | 2022-11-29 | Biocheminsights, Inc. | Methods and systems for 1-butanol production |
EP3316375B1 (en) | 2015-06-23 | 2020-03-18 | Panasonic Intellectual Property Management Co., Ltd. | Redox flow cell |
WO2017160793A1 (en) | 2016-03-14 | 2017-09-21 | Biocheminsights, Inc. | Improved method for using electrochemical bioreactor module with recovery of cofactor |
Also Published As
Publication number | Publication date |
---|---|
BR112015005172B1 (en) | 2021-07-20 |
US20150228996A1 (en) | 2015-08-13 |
CN104871357A (en) | 2015-08-26 |
EP2893587B1 (en) | 2020-04-29 |
US11929532B2 (en) | 2024-03-12 |
CA2923794A1 (en) | 2014-03-13 |
BR112015005172A2 (en) | 2017-07-04 |
EP2893587A1 (en) | 2015-07-15 |
EP2893587A4 (en) | 2016-05-18 |
CA2923794C (en) | 2021-07-27 |
HK1214412A1 (en) | 2016-07-22 |
CN104871357B (en) | 2018-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11929532B2 (en) | Electrochemical bioreactor module and methods of using the same | |
Fornero et al. | Electric power generation from municipal, food, and animal wastewaters using microbial fuel cells | |
Rojas et al. | Effect of the electric supply interruption on a microbial electrosynthesis system converting inorganic carbon into acetate | |
Lee et al. | Biological hydrogen production: prospects and challenges | |
Kyazze et al. | Influence of catholyte pH and temperature on hydrogen production from acetate using a two chamber concentric tubular microbial electrolysis cell | |
Davis et al. | Biofuel cells—recent advances and applications | |
Mostafazadeh et al. | Microbial electrosynthesis of solvents and alcoholic biofuels from nutrient waste: A review | |
JP2012512326A (en) | Process for the production of chemicals | |
CN107250436B (en) | Improved electrochemical bioreactor module and use thereof | |
CN110078225B (en) | Microbial electrolytic cell and synchronous CO for organic oxidative degradation 2 Methanation process | |
Liu et al. | Recent progress on microbial electrosynthesis reactor designs and strategies to enhance the reactor performance | |
Song et al. | Experimental evaluation of the influential factors of acetate production driven by a DC power system via CO 2 reduction through microbial electrosynthesis | |
Bajracharya et al. | Bioelectrochemical syntheses | |
Neto et al. | Microbial fuel cells and wastewater treatment | |
Scott | An introduction to microbial fuel cells | |
Chen et al. | Carbon dioxide reduction to high–value chemicals in microbial electrosynthesis system: Biological conversion and regulation strategies | |
US10777835B2 (en) | Biological-alkali ion hybrid battery | |
KR100841736B1 (en) | A system for bioelectrochemical hydrogen production using sun light | |
Azuma et al. | Catalyst development of microbial fuel cells for renewable-energy production | |
Noori et al. | Hydrogen production in microbial electrolysis cells with biocathodes | |
Syed et al. | Electroactive biofilm and electron transfer in microbial electrochemical systems | |
PARK et al. | Electrochemical control of metabolic flux of Weissella kimchii sk10: Neutral red immobilized in cytoplasmic membrane as electron channel | |
Fontmorin et al. | 27. Carbon dioxide utilisation by bioelectrochemical systems through microbial electrochemical synthesis | |
Sonawane et al. | Microbial electrosynthesis for bio-based production using renewable electricity | |
Speers et al. | Theoretical and practical considerations for culturing Geobacter biofilms in microbial fuel cells and other bioelectrochemical systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13835540 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14426828 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013835540 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015005172 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2923794 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 112015005172 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150309 |